Abstract:Ethnopharmacological relevance: Glycyrrhiza glabra L., a traditional medicinal, has a history of thousands of years. It is widely used in clinic and has been listed in Chinese Pharmacopoeia. Licochalcone A is a phenolic chalcone compound and a characteristic chalcone of Glycyrrhiza glabra L. It has many pharmacological activities, such as anti-cancer, anti-inflammatory, anti-viral and anti-angiogenic activities.& nbsp; Aim of the study: In this study, we explored the anti-tumor activity and potential mechanism of licochalcone A in vitro and in vivo.& nbsp; Materials and methods: In vitro, the mechanism of licochalcone A at inhibiting PD-L1 expression was investigated by molecular docking, western blotting, RT-PCR, flow cytometry, immunofluorescence and immunoprecipitation assays. The co-culture model of T cells and tumor cells was used to detect the activity of cytotoxic T lymphocytes. Colony formation, EdU labelling and apoptosis assays were used to detect changes in cellular proliferation and apoptosis. In vivo, anti-tumor activity of licochalcone A was assessed in a xenograft model of HCT116 cells.& nbsp; Results: In the present study, we found that licochalcone A suppressed the expression of programmed cell death ligand-1 (PD-L1), which plays a key role in regulating the immune response. In addition, licochalcone A inhibited the expressions of p65 and Ras. Immunoprecipitation experiment showed that licochalcone A suppressed the expression of PD-L1 by blocking the interaction between p65 and Ras. In the co-culture model of T cells and tumor cells, licochalcone A pretreatment enhanced the activity of cytotoxic T lymphocytes and restored the ability to kill tumor cells. In addition, we showed that licochalcone A inhibited cell proliferation and promoted cell apoptosis by targeting PD-L1. In vivo xenograft assay confirmed that licochalcone A inhibited the growth of tumor xenografts.& nbsp; Conclusion: In general, these results reveal the previously unknown properties of licochalcone A and provide new insights into the anticancer mechanism of this compound.

Lz-207, A Newly Synthesized Flavonoid, Induces Apoptosis And Suppresses Inflammation-Related Colon Cancer By Inhibiting The Nf-Kappa B Signaling Pathway

Activation of Endoplasmic Reticulum Stress and the Extrinsic Apoptotic Pathway in Human Lung Cancer Cells by the New Synthetic Flavonoid, Lz-205

Isofraxidin Inhibited Proliferation and Induced Apoptosis Via Blockage of Akt Pathway in Human Colorectal Cancer Cells

LW-214, a Newly Synthesized Flavonoid, Induces Intrinsic Apoptosis Pathway by Down-Regulating Trx-1 in MCF-7 Human Breast Cells

LFG-500, a newly synthesized flavonoid, attenuates lipopolysaccharide-induced acute lung injury and inflammation in mice.

Anti-tumor Activity in Colorectal Cancer Induced by Hinokiflavone.

GEN-27, a Newly Synthetic Isoflavonoid, Inhibits the Proliferation of Colon Cancer Cells in Inflammation Microenvironment by Suppressing NF-κB Pathway

LL-202, a Newly Synthesized Flavonoid, Inhibits Tumor Growth Via Inducing G(2)/M Phase Arrest and Cell Apoptosis in MCF-7 Human Breast Cancer Cells in Vitro and in Vivo.

NF- κ B and Nrf2 signaling pathways contribute to wogonin-mediated inhibition of inflammation-associated colorectal carcinogenesis

The Flavones Induce Breast Cancer Cell Apoptosis Via Activation Foxo3a

Luteolin suppressed growth of colon tumor via inflammation, oxidative stress, and NLRP3/IL-1β signal axis

LFG-500, a Newly Synthesized Flavonoid, Induced a Reactive Oxygen Species-Mitochondria-mediated Apoptosis in Hepatocarcinoma Cells

LYG-202, a new flavonoid with a piperazine substitution, shows antitumor effects in vivo and in vitro.

New Synthetic Flavone Derivatives Induce Apoptosis of Hepatocarcinoma Cells.

Discovery of a Potential Multi-Target Anti-Tumor Agent Via Structural Modification on Flavonoid

Licochalcone A Inhibits Proliferation and Promotes Apoptosis of Colon Cancer Cell by Targeting Programmed Cell Death-Ligand 1 Via the NF-κB and Ras/Raf/MEK Pathways.

LFG-500, a newly synthesized flavonoid, induces apoptosis in human ovarian carcinoma SKOV3 cells with involvement of the reactive oxygen species-mitochondria pathway

Flavonoids Inhibit Cell Proliferation And Induce Apoptosis And Autophagy Through Downregulation Of Pi3k Gamma Mediated Pi3k/Akt/Mtor/P70s6k/Ulk Signaling Pathway In Human Breast Cancer Cells

Design, synthesis and biological evaluation of 3',4',5'-trimethoxy flavonoid benzimidazole derivatives as potential anti-tumor agents.

8-Methoxyflindersine-Induced Apoptosis and Cell Cycle Disorder Involving MAPK Signaling Activation in Human Colorectal Cancer Cells

Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3Kγ mediated PI3K/AKT/mTOR/p70S6K/ULK signaling pathway in human breast cancer cells